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Aziridine Opening
Ammonium Salt-Catalyzed Ring-Opening of Aryl-Aziridines with
-Keto Esters
Victoria Haider,[a] Viktoria Kreuzer,[a] Maximilian Tiffner,[a] Bernhard Spingler,[b] and
Mario Waser*[a]
Abstract: We herein report an ammonium salt-catalyzed proto-
col for the regioselective ring opening of aryl-aziridines with
-keto esters. The reaction gives access to a variety of highly
Introduction
Aziridines have been established as interesting building blocks
for a variety of (asymmetric) transformations and their synthetic
versatility can be attributed to the fact that they easily undergo
ring opening reactions with a variety of different nucleo-
philes.[1] In addition, a broad variety of (chiral) aziridines can be
accessed straightforwardly (racemic or enantiopure) by estab-
lished synthesis strategies starting from simple precursors,[1,2]
making approaches relying on aziridine opening reactions very
appealing. The reactions of aziridines with C-nucleophiles, i.e.
enolate species, can lead to interesting γ-amino-carbonyl tar-
gets which are not easily accessible by other strategies. In addi-
tion, depending on the aziridine substitution pattern, rather
complex structural motives containing two or even three con-
secutive stereogenic centers can be accessed (Scheme 1A) and
the use of a chiral catalyst may allow to control such reactions
in a stereoselective manner.[1,3–6]
Our group has a strong interest in asymmetric ion pairing
catalysis[7–10] and we recently reported that bifunctional
ammonium salt catalysts[8] containing a (thio)-urea H-bonding
motive (i.e. catalysts A) can be used for the asymmetric α-
hydroxylation of -keto esters 1 by using racemic oxaziridines
2 as the O-transfer reagents (accompanied by a simultaneous
resolution of the oxaziridines 2 as outlined in Scheme 1B).[10]
Based on the general interest in aziridine-opening reactions
and given our focus on asymmetric ammonium salt catalysis
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functionalized target molecules with two consecutive stereo-
genic centers and can be rendered enantioselective (up to e.r. =
91:9) by using bifunctional chiral ammonium salt catalysts.
Scheme 1. General reactivity of aziridines towards nucleophilic attack (A),
our recently developed asymmetric α-hydroxylation of -keto esters 1 with
oxaziridines 2 (B), and the herein investigated addition of compounds 1 to
aryl-aziridines 4 (C).
we now wanted to explore if ammonium salt catalysts (like
compounds A) may also facilitate the addition of pronucleo-
philes 1 to aryl-aziridines 4. In general, the asymmetric ring-
opening of aziridines with -keto esters 1 using chiral ammon-
ium salt catalysts has been well-investigated, i.e. by the groups
of Dixon and Jørgenson.[4] However, in those cases no aryl-azir-
idines 4 were used and to the best of our knowledge there are
only very few reports in general, where enolate precursors were
added to such aziridines in an asymmetric manner.[5] Interest-
ingly, some previous reports describing the addition of
malonates to such aziridines in the absence of a chiral catalyst
showed that these reagents predominately undergo nucleo-
phile addition to the benzylic position of the aziridine, and that
these reactions proceed via a stereospecific ring-opening path-
way with inversion of configuration of the benzylic stereogenic
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for the regio- and stereoselective addition of pronucleophiles 1
to (racemic) aziridines 4, which would result in the formation
of the highly functionalized target molecules 5 (Scheme 1C).
Results and Discussion
We started our investigations by carrying out the reaction be-
tween the tert-butyl ester 1a and the phenyl aziridine 4a. The
reason why we opted for the N-tosyl protected 4a was because
we previously (during the hydroxylation of 1 with oxaziridines
2) realized that sulfonamide groups provide a very good point
of coordination for our bifunctional ammonium salts A.[10] Be-
sides our own catalysts A[10,11] (on which we put our main fo-
cus), we also compared the other classical and well-established
ammonium salt catalysts B[7,12] and C[7,13] and the recently re-
ported bifunctional Cinchona alkaloid derivative D.[14]
First experiments without any catalyst (entry 1) and in the
presence of a simple achiral ammonium salt (entry 2) clearly
proved the beneficial effect of the phase-transfer catalyst and
showed that the reaction proceeds via addition to the benzylic
carbon of the aziridine (giving 5a). The relative configuration of
the major diastereomer of product 5a was assigned by single-
crystal X-ray analysis[15] and in all further experiments the unlike
diastereomer was found to be the main product. We then carried
out a first base screening with our urea-containing catalyst A1
(entries 3–6) and found that the targeted product 5a could be
obtained in a reasonable yield of 79 % and with promising enan-
tio- and diastereoselectivities (d.r. = 6:1; e.r. = 89:11) after 24 h
when using two equivalents of solid Cs2CO3 (entry 6). The use of
aqueous bases on the other hand significantly slowed down the
conversion (entry 4) and stronger bases (e.g. NaOH) were found
to be not suited at all (results not given in the table), i.e. as
the aziridine decomposed significantly under these conditions.
Interestingly, while the major diastereomer could be obtained
with a good enantiomeric ratio of 89:11, the minor diastereomer
was formed in an almost racemic manner (entry 6).
We then tested other derivatives of the bifunctional ammon-
ium salts A (entries 7–9 give three representative examples),
but neither the use of a thiourea (entry 7), nor using sterically
more bulky systems (entry 9) resulted in any improvement.
When using the well-established Maruoka catalyst B next (entry
10),[7,12] the reaction stalled after around 50 % conversion and
the observed diastereoselectivity was rather low (d.r. = 1.5:1). In
sharp contrast to ammonium salt A1 however, catalyst B al-
lowed for higher enantioselectivities of the minor diastereomer
(favoring the same major enantiomers of both diastereomers as
A1). The classical Cinchona alkaloid ammonium salts C were
found to be less suited for this reaction (entries 11 and 12),
while the bifunctional catalyst D[14] gave at least some levels
of selectivity (entry 13), although clearly not as promising as
compounds A.
Based on these results, which support a beneficial effect of
the bifunctional nature of the catalyst, we then tried to further
optimize the reaction conditions using A1 (entries 14–18).
While non-aromatic solvents were found to be less suited (en-
tries 14, 15), the use of a lower amount of base resulted in a
slightly increased enantioselectivity of 91:9 (compare entries 16
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and 6). However, the yield was noticeable lower, and we found
that actually this reaction stalled after around 60 % conversion,
requiring addition of more base to proceed to completion.
When carrying out the reaction under more concentrated con-
ditions, the yield improved slightly, while the enantioselectivity
decreased (entry 17). This result is in line with our recent obser-
vations for the α-hydroxylation of compounds 1, where higher
dilution was beneficial for high enantioselectivities as well.[10]
Finally, lowering the catalyst loading to 5 mol-% resulted in a
slightly lower selectivity but in a noteworthy reduced yield.
Again, the reaction stalled after a while and addition of more
catalyst was necessary in those cases, while longer reaction
times were not beneficial. This phenomenon was generally ob-
served in all the other reactions that did not show a satisfying
conversion after 24 h (compare with entries 4, 10, and 16).
Lower temperatures were tried as well but the reactions be-
came very slow with unreliable conversions and no benefit in
enantioselectivity.
Unfortunately, during these optimization attempts we ob-
served a very strong influence of the starting material quality
on the stereoselectivity of the reaction. First, the aziridine 4 has
to be rather clean and especially even very minor quantities of
iodine residues originating from the synthesis route[16] lead to
a significant decrease of the e.r. In addition, the used -keto
ester 1 has to be “perfectly clean” as well, as we observed that
batches of 1a that contained very small quantities of unidenti-
fied impurities (less than 1 % by 1H NMR) resulted in reduced
enantioselectivities down to e.r. = 75:25 under otherwise identi-
cal conditions (in addition the yields were a bit higher here,
demonstrating the notable influence of these unknown impuri-
ties on the reaction performance). Thus, use tests of each batch
of the starting materials had to be made during all these opti-
mizations. In sharp contrast to this pronounced sensitivity on
the starting material quality observed for the synthesis of 5,
use tests of different keto ester 1a batches for other reactions
catalyzed by catalysts A (like the above mentioned α-hydroxyl-
ation[10] or analogous α-halogenations[17]) revealed no measur-
able dependency of selectivity and/or yield therein. Accord-
ingly, this rather unpractical sensitivity, where seemingly small
impurities or changes in the reagent's quality affected the out-
come significantly, required a tedious purification of the start-
ing materials for all asymmetric experiments. As a consequence,
the results given in entries 6 and 16 in Table 1 are the best we
could obtain with carefully purified reagents only. On the other
hand, it should be noted that with given qualities of a single
batch of 1a and/or 4a reproducible results were obtained when
repeating the experiments several times.
During our A1-catalyzed α-hydroxylation of 1 with oxazir-
idines 2 we also observed a practical simultaneous kinetic reso-
lution of compounds 2 (up to s = 45)[10] and we therefore spec-
ulated that a resolution may be possible for our herein used
aziridine 4a too. We thus carried out the addition of 1a to rac-
4a (2 equiv.) under the optimized conditions (entry 16, Table 1)
and observed some moderate enantioenrichment of recovered
4a as well [e.r. = 60:40 for (S)-4a after 25 % conversion; s = 4.8].
Giving the significantly lower stereoselectivity in the synthesis
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Table 1. Catalyst screening and optimization of the asymmetric reaction con-
ditions.[a]
Entry Catalyst Solvent Base Yield d.r.[c] e.r.major
[d]
[mol-%] [%][b]
1 – toluene K2CO3 (2 ×) < 5 – –
2 TBAB[e] toluene K2CO3 (2 ×) 49 3:1 –
(10 %)
3 A1 (10 %) toluene K2CO3 (2 ×) 66 3.5:1 85:15
4 A1 (10 %) toluene K2CO3 (50 % 21
[f] 4:1 86:14
aq.; 2 ×)
5 A1 (10 %) toluene K2HPO4 (2 ×) 71 2:1 76:24
6 A1 (10 %) toluene Cs2CO3 (2 ×) 79 6:1 89:11
(56:44)[g]
7 A2 (10 %) toluene Cs2CO3 (2 ×) 60 2.5:1 63:37
8 A3 (10 %) toluene Cs2CO3 (2 ×) 72 1.5:1 81:19
9 A4 (10 %) toluene Cs2CO3 (2 ×) 54 2:1 82:18
10 B (10 %) toluene Cs2CO3 (2 ×) 39
[f] 1.5:1 70:30
(86:14)[g]
11 C1 (10 %) toluene Cs2CO3 (2 ×) 89 2:1 52:48
12 C2 (10 %) toluene Cs2CO3 (2 ×) 90 3:1 50:50
13 D (10 %) toluene Cs2CO3 (2 ×) 82 3:1 64:36
14 A1 (10 %) MTBE Cs2CO3 (2 ×) 75 4:1 87:13
15 A1 (10 %) CH2Cl2 Cs2CO3 (2 ×) 84 3:1 66:34
16 A1 (10 %) toluene Cs2CO3 (1 ×) 56 8:1 91:9
17 A1 (10 %) toluene[h] Cs2CO3 (2 ×) 83 5:1 81:19
18 A1 (5 %) toluene Cs2CO3 (2 ×) 36
[f] 7:1 87:13
[a] All reactions were run at room temperature using 0.1 mmol 1a and
0.2 mmol rac-4a for 24 h in the indicated solvent (0.02 M with respect to 1a)
unless otherwise stated. [b] Isolated yields of both diastereomers. [c] Deter-
mined by 1H NMR and/or HPLC analysis of the crude product. [d] Determined
by HPLC using a chiral stationary phase. [e] Tetrabutylammonium bromide.
[f ] Less than 50–60 % conversion. [g] e.r. of the minor diastereomer. [h] 0.1 M
with respect to 1a.
ciency for the simultaneous resolution of 4a comes as no sur-
prise, but nevertheless this result supports our initial hypothe-
sis.
To gather further information about this aziridine-opening
reaction, we next carried out the addition of 1a to enantiopure
(R)-4a[18] in the presence of either (R,R)-A1 or (S,S)-A1 as a cata-
lyst (Scheme 2).
In both cases, the two diastereomers of 5a were formed with
complete enantiospecifity, supporting an SN2-mechansim for
the ring opening, as observed by others as well.[6] The use of
the (R,R)-catalyst enantiomer (which was also used during the
screening summarized in Table 1) lead to a reasonable dia-
stereoselectivity of 6:1 in favor of the major unlike diastereomer
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Scheme 2. Match/mismatch scenario in the addition of 1a to (R)-4a in the
presence of both enantiomers of the catalyst A1 and the proposed match-
transition state.
with high yield (match case). On the other hand, the reaction
with the (S,S)-catalyst proceeded significantly slower and with
much lower diastereoselectivity (mismatch case). In our previ-
ous investigations on the use of catalysts A for reactions of
-keto esters 1 we observed that the (S,S)-catalyst enantiomers
always favor Re-face addition of the nucleophile.[10,17] In addi-
tion, previous DFT calculations of the A1-catalyzed α-hydroxyl-
ation of 1a with 2 support a transition state where the enolate
is H-bonded to the urea moiety, while the electrophile is coordi-
nated to the ammonium group.[10,19] Based on these previous
observations, the herein observed pronounced match/mis-
match behavior in the stereospecific addition to enantiopure
aziridine 4a, and the unambiguously determined relative con-
figuration of 4a,[15] the (R,R)-catalyst is supposed to interact
with both starting materials 1a and 4a in an organized bifunc-
tional manner as illustrated in Scheme 2, rationalizing formation
of the observed favored major stereoisomer (S,R)-5a. Based on
this model it can also be proposed that the slightly preferred
enantiomer of the minor like diastereomer is (S,S)-5a.
Summing these investigations up, it was demonstrated that
the stereoselective addition of pronucleophile 1a to aziridine
4a can be controlled by using the bifunctional ammonium salts
A. Unfortunately however, because of the unexpected pro-
nounced sensitivity that we observed during all these test reac-
tions, and despite the promising selectivities up to e.r. = 91:9,
this reaction as such is far from being as robust and practical
as other chiral ammonium salt catalyzed reactions that we in-
vestigated recently.[9,10,17]
Considering the novelty of the products 5 that are accessible
by this strategy in general, but keeping in mind the practical
limitations of the asymmetric protocol, i.e. the sensitivity to the
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scope for the racemic phase transfer-catalyzed addition of vari-
ous -keto esters 1 to aryl-aziridines 4 only.
As shown in Scheme 3, a variety of differently functionalized
pronucleophiles 1 and acceptors 4 were reacted for three days
in the presence of benzyltriethylammonium chloride (TEBAC)
using Cs2CO3 (a) or K3PO4 (b) as the base. Interestingly, mesyl-
ated aziridines did not react well (see the result given for prod-
uct 5b) and when using N-Boc aziridines no reaction was ob-
served at all. On the other hand, the use of methyl or benzyl
esters revealed a strong influence of this group on the overall
outcome, as both of them resulted in the direct formation of
the spirocyclic γ-lactam 6 upon addition to aziridine 4a. Differ-
ent substituents on the donor side were tolerated (see products
5e–i), although in some of these cases the use of K3PO4 was
found to be beneficial over Cs2CO3 (in the latter case significant
amounts of decomposition products were observed). On the
other hand, variations of the acceptor aryl group were generally
well accepted in the 4-position, independent of the nature of
the base, while the 3-position was lower yielding (see product
55) and in this case again significant amounts of unidentified
decomposition products were formed. Nevertheless, the race-
mic protocol generally gives access to a variety of differently
functionalized products 5 with relatively good yields and rea-
sonable diastereoselectivities under these operationally simple
ammonium salt-catalyzed conditions.
Scheme 3. Application scope of the racemic ammonium salt-catalyzed ring-
opening of aryl-aziridines 4 with -keto esters 1.
Conclusions
Summing these investigations up, we have shown that -keto
esters 1 react with aryl-aziridines 4 under (chiral) ammonium
salt catalysis giving access to highly functionalized products 5.
In principle a catalytic and reasonably enantioselective protocol
could be developed by using the bifunctional ammonium salt
catalysts A. Unfortunately, however, this reaction was found to
be very sensitive towards the quality of the starting materials.
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Nevertheless, control experiments showed a pronounced
match/mismatch behavior of the bifunctional catalyst and the
used aziridine, thus pointing towards a mechanism where the
catalyst simultaneously activates both of the reaction partners.
Experimental Section
General experimental and analytical details as well as the character-
ization data of all the novel compounds can be found in the online
supporting information.
Racemic Protocol: A mixture of 0.1 mmol -keto ester 1 (1 equiv.),
2.2 mg of TEBAC (0.01 mmol, 10 mol-%) and 0.2 mmol base
(2 equiv.) was dissolved in 5 mL of toluene (Ar-atmosphere). Then
0.2 mmol of aziridine 4 (2 equiv.) were added in one portion. After
a reaction time of three days the mixture was filtered through a
plug of Na2SO4 and washed with DCM. The crude product, obtained
after evaporation of the solvent, was subjected to column chroma-
tography (silica gel, heptanes:EtOAc = 5:1) to isolate products 5 and
6 as mixtures of diastereomers. The diastereomers were in some
cases separated using preparative HPLC (Grace Alltima Silica 10 μm
250 × 10 mm, n-hexane/EtOAc, 5 mL/min).
Enantioselective Screening Protocol: A mixture of the -keto es-
ter 1a (0.1 mmol, 1 equiv.), catalyst A1 (7.6 mg, 0.01 mmol, 10 mol-
%) and 0.2 mmol of the tested base (2 equiv.) were dissolved in 5
mL of the given solvent (argon atmosphere, room temperature).
Then 48 mg of 2-phenyltosylaziridine 4a (0.2 mmol, 2 equiv.) were
added in one portion. After a reaction time of one day the mixture
was filtered through a plug of Na2SO4 and washed with DCM. The
crude product, obtained after evaporation of the solvent under re-
duced pressure, was then subjected to column chromatography pu-
rification (silica gel, heptanes:EtOAc = 2:1) to isolate product 5a as
a mixture of two diastereomers (d.r. up to 8:1) in yields up to 84 %.
The diastereomers were separated using preparative HPLC (Grace
Alltima Silica 10 μm 250 × 10 mm, n-hexane/EtOAc = 9:1, 5 mL/min,
retention times: 39.1 min major, 46.8 min minor). The enantiomeric
excess of the minor diastereomer was determined by HPLC using a
YMC Amylose SA column (n-hexane/iPrOH = 3:1, 1 mL/min, 10 °C,
retention times: 21.0 and 35.5 min). The enantiomeric excess of the
major diastereomer was determined by HPLC using a YMC Cellulose
SB column (n-hexane/iPrOH = 10:1, 1 mL/min, 10 °C, retention
times: 22.2 min major, 20.2 min minor).
Analytical Details for Compound 5a: HRMS (ESI): m/z calculated
for C29H32NO5S
+: 506.2001 [M + H]+, found 506.1992. Major Dia-
stereomer: 1H-NMR (700 MHz, CDCl3, 298.0 K): δ /ppm = 7.67 (d, J =
8.2 Hz, 2H), 7.49 (d, J = 7.7 Hz, 1H), 7.46 (t, J = 7.2 Hz, 1H), 7.32 (d,
J = 7.7 Hz, 1H), 7.28 (d, J = 8.2 Hz, 2H), 7.21 (t, J = 7.2 Hz, 1H), 7.11–
7.05 (m, 5H), 4.42–4.40 (m, 1H), 3.87 (dd, J1 = 9.7 Hz, J2 = 5.7 Hz,
1H), 3.69 (d, J = 17.2 Hz, 1H), 3.65–3.61 (m, 1H), 3.38–3.34 (m, 1H),
3.22 (d, J = 17.2 Hz, 1H), 2.43 (s, 3H), 1.37 (s, 9H); 13C-NMR (176 MHz,
CDCl3, 298.0 K): δ /ppm = 200.7, 169.0, 153.2, 143.6, 137.2, 136.2,
135.2, 135.0, 129.9, 129.6, 128.7, 127.8, 127.6, 127.3, 126.0, 124.7,
83.1, 65.4, 48.0, 44.4, 33.3, 27.8, 21.6. Minor Diastereomer: 1H-NMR
(700 MHz, CDCl3, 298.0 K): δ /ppm = 7.73 (d, J = 7.5 Hz, 2H), 7.56
(d, J = 8.1 Hz, 2H), 7.56–7.54 (m, 1H), 7.37–7.34 (m, 2H), 7.22–7.18
(m, 5H), 7.11–7.08 (m, 2H), 4.20–4.18 (m, 1H), 3.90–3.88 (m, 1H), 3.64
(d, J = 16.8 Hz, 1H), 3.40–3.36 (m, 1H), 3.33–3.29 (m, 1H), 3.27 (d,
J = 16.8 Hz, 1H), 2.40 (s, 3H), 1.20 (s, 9H); 13C-NMR (176 MHz, CDCl3,
298.0 K): δ /ppm = 202.1, 168.5, 153.2, 143.4, 137.9, 137.0, 135.7,
135.4, 129.8, 129.2, 128.8, 127.9, 127.8, 127.2, 126.3, 124.7, 82.8, 65.2,
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1. General Information 
 
1.1. General Methods 
Solvents and reagents were purchased from commercial suppliers and were used without 
further purification unless otherwise mentioned. Anhydrous solvents were dried using a 
molecular sieve drying plant. All reactions were performed under an argon atmosphere. TLC 
analysis were carried out using Macherey-Nagel pre-coated TLC sheets Alugram ® Xtra SIL 
G/UV with detection at 254 nm. For column chromatography Davisil LC 60A 70-200 MICRON 
silica gel was used. HPLC was performed using a Dionex Summit HPLC system with a YMC 
Chiral Art Cellulose - SB (250 x 4.6 mm, 5 µm) and a YMC Chiral Art Amylose SA (250 x 4.6 
mm, 5 µm) chiral stationary phase. Preparative HPLC was carried out using a Thermo 
Scientific Dionex Ultimate 3000 system with variable wavelength detection and a Grace 
Alltima Silica 10µm 250x10 mm column. 1H- and 13C-NMR spectra were recorded using a 
Bruker Avance III 300 MHz spectrometer with a broad band observe probe and a sample 
changer for 16 samples, a Bruker Avance DRX 500 MHz spectrometer, and a Bruker Avance 
III 700 MHz spectrometer with an Ascend magnet and TCI cryoprobe of the Austro-Czech 
NMR-Research Center. High resolution mass spectra were obtained using a Thermo Fisher 
Scientific LTQ Orbitrap XL with an Ion Max API Source.  
Chiral catalysts A1, starting b-ketoesters 12, and racemic3 and enantiopure4 aziridines 4 were 
synthesized as described previously. 
 
  
                                                             
1 M. Tiffner, J. Novacek, A. Busillo, K. Gratzer, A. Massa, M. Waser, RSC Adv. 2015, 5, 78941-78949. 
2 a) Y.-N. Duan, L.-Q. Cui, L.-H. Zuo, C. Zhang, Chem. Eur. J. 2015, 21, 13052-13057; b) X. Gu, Y. 
Zhang, Z.-J. Xu, C.-M. Che, Chem. Commun. 2014, 50, 7870-7873; c) I. Geibel, J. Christoffers, Eur. J. 
Org. Chem. 2016, 918-920; d) A. M. R. Smith, H. S. Rzepa, A. J. P. White, D. Billen, K. K. M. Hii, J. Org. 
Chem. 2010, 75, 3085-3096. 
3 H. Rubin, J. Cockrell, J. B. Morgan, J. Org. Chem. 2013, 78, 8865-8871. 





1.2. Single-Crystal Analysis 
 
Crystallographic data were collected at 160.0(1) K on a Rigaku-Oxford Diffraction 
XtaLAB Synergy-S dual source diffractometer. This is a kappa-axis four-circle 
goniometer with a Dectris Pilatus3 R 200K HPC (Hybrid Photon Counting) detector and 
Cu and Mo PhotonJet microfocus X-ray sources. A suitable crystal was covered with oil 
(Infineum V8512, formerly known as Paratone N), placed on a nylon loop that is mounted 
on a CrystalCap Magnetic™ pin (Hampton Research) and immediately transferred to 
the diffractometer. The program suite CrysAlisPro was used for data collection, numerical 
and multi-scan absorption correction as well as data reduction.5 The structure was 
solved with the dual-space algorithm using SHELXT6 and was refined by full-matrix 
least-squares methods on F2 with SHELXL-20187 using the Olex2 GUI.8 Compound 5a 
crystallized in the chiral space group C2 with a Flack parameter of 0.011(6) (S 
configuration at C1 and R configuration at C15). The sulfonylamide methylene unit was 
disordered in a ratio 78:22. The graphical output was produced with the help of the 
program Mercury.9[5] CCDC 2012449 contains the supplementary crystallographic data 
for this paper. These data are provided free of charge by The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures. 
 
                                                             
5 CrysAlisPro Software system; Rigaku Oxford Diffraction, vers. 1.171.40; Rigaku Corporation, 2019. 
6 G. M. Sheldrick, Acta Cryst. 2015, A71, 3. 
7 G. M. Sheldrick, Acta Cryst. 2015, C71, 3. 
8 O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard, H. Puschmann, J. Appl. Cryst. 2009, 42, 
339. 
9 C. F. Macrae, L. Sovago, S. J. Cottrell, P. T. A. Galek, P. McCabe, E. Pidcock, M. Platings, G. P. Shields, 






Fig. S1: Displacement ellipsoid representation of compound 5a at 50% probability. 










Table S1.  Crystal data and structure refinement for 5a. 
Empirical formula  C29H31NO5S 
Formula weight  505.61 
Crystal system  Monoclinic 
Space group  C2 
a [Å]  20.65539(16)  
b [Å]  5.88663(4)  
c [Å]  22.57135(19)  
a [°]  90 
b [°]  103.4741(9) 
g [°]  90 
Volume [Å3]  2668.92(4)  
Z 4 
Density (calculated) [Mg/m3]  1.258  
Temperature [K]  160.01(10)  
Wavelength [Å]  1.54184  
Absorption coefficient [mm-1]  1.392 
F(000) 1072 
Crystal size [mm3]  0.594 x 0.122 x 0.101  
Crystal description colourless needle 
Theta range for data collection [°]  4.028 to 79.558 
Index ranges -21<=h<=26, -7<=k<=7, -27<=l<=28 
Reflections collected 31300 
Independent reflections 5436 [R(int) = 0.0260] 
Reflections observed 5380 
Criterion for observation I > 2 s (I)  
Completeness to theta  94.4 % to 67.684°  
Absorption correction Gaussian 
Max. and min. transmission 1.000 and 0.344 
Data / restraints / parameters 5436 / 98 / 375 
Goodness-of-fit on F2 1.057 
Final R indices [I > 2 s (I)] R1 = 0.0359, wR2 = 0.0973 
R indices (all data) R1 = 0.0365, wR2 = 0.0997 
Absolute structure parameter 0.011(6) 





Table S2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for 5a.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
S(1) 8205(1) 2033(3) 6408(1) 47(1) 
S(1B) 8032(2) 1079(8) 6507(2) 35(1) 
O(1) 7625(1) 8928(3) 8714(1) 41(1) 
O(2) 6758(1) 8461(3) 7220(1) 50(1) 
O(3) 6062(1) 6663(3) 7694(1) 42(1) 
O(4) 8702(1) 2763(6) 6099(1) 59(1) 
O(4B) 8568(6) 2419(15) 6344(5) 40(2) 
O(5) 8269(2) -115(7) 6715(1) 56(1) 
O(5B) 8137(6) -1327(19) 6624(4) 44(2) 
N(1) 8190(1) 4008(6) 6910(1) 46(1) 
N(1B) 7887(4) 2274(17) 7123(4) 39(2) 
C(1) 7199(1) 5772(4) 8029(1) 33(1) 
C(2) 7325(1) 7146(4) 8630(1) 32(1) 
C(3) 7005(1) 5926(4) 9056(1) 34(1) 
C(4) 6922(1) 6627(5) 9621(1) 44(1) 
C(5) 6588(1) 5176(6) 9934(1) 55(1) 
C(6) 6346(1) 3104(6) 9681(1) 57(1) 
C(7) 6430(1) 2420(5) 9123(1) 48(1) 
C(8) 6764(1) 3858(4) 8803(1) 37(1) 
C(9) 6933(1) 3458(4) 8199(1) 37(1) 
C(10) 6655(1) 7126(4) 7592(1) 35(1) 
C(11) 5430(1) 7480(4) 7291(1) 41(1) 
C(12) 4920(1) 6420(6) 7596(2) 58(1) 
C(13) 5377(2) 6555(5) 6660(1) 55(1) 
C(14) 5390(2) 10036(5) 7306(2) 56(1) 
C(15) 7830(1) 5691(4) 7766(1) 38(1) 
C(16) 8482(1) 5315(4) 8225(1) 36(1) 
C(17) 8643(1) 3348(5) 8560(1) 51(1) 
C(18) 9247(1) 3114(6) 8979(2) 59(1) 
C(19) 9705(1) 4849(5) 9072(1) 54(1) 
C(20) 9560(1) 6788(5) 8729(2) 61(1) 
C(21) 8959(1) 7018(5) 8315(1) 53(1) 
C(22) 7686(2) 3834(7) 7272(2) 42(1) 





C(23) 7408(1) 1936(6) 5885(1) 55(1) 
C(24) 7269(1) 3756(6) 5487(1) 58(1) 
C(25) 6678(1) 3796(6) 5053(1) 56(1) 
C(26) 6219(1) 2023(6) 4991(1) 55(1) 
C(27) 6366(2) 242(7) 5402(2) 63(1) 
C(28) 6954(2) 198(7) 5853(1) 64(1) 






Table S3.   Bond lengths [Å] and angles [°] for  5a. 
_____________________________________________________  
S(1)-O(4)  1.435(3) 
S(1)-O(5)  1.433(4) 
S(1)-N(1)  1.629(3) 
S(1)-C(23)  1.789(3) 
S(1B)-O(4B)  1.475(10) 
S(1B)-O(5B)  1.448(10) 
S(1B)-N(1B)  1.647(10) 
S(1B)-C(23)  1.744(4) 
O(1)-C(2)  1.211(3) 
O(2)-C(10)  1.206(3) 
O(3)-C(10)  1.326(3) 
O(3)-C(11)  1.486(3) 
N(1)-C(22)  1.468(4) 
N(1B)-C(22B)  1.480(17) 
C(1)-C(2)  1.548(3) 
C(1)-C(9)  1.549(3) 
C(1)-C(10)  1.534(3) 
C(1)-C(15)  1.554(3) 
C(2)-C(3)  1.472(3) 
C(3)-C(4)  1.390(3) 
C(3)-C(8)  1.387(3) 
C(4)-C(5)  1.390(4) 
C(5)-C(6)  1.391(5) 
C(6)-C(7)  1.371(4) 
C(7)-C(8)  1.396(3) 
C(8)-C(9)  1.502(3) 
C(11)-C(12)  1.520(4) 
C(11)-C(13)  1.506(4) 
C(11)-C(14)  1.507(4) 
C(15)-C(16)  1.513(3) 
C(15)-C(22)  1.541(4) 
C(15)-C(22B)  1.625(12) 
C(16)-C(17)  1.380(3) 
C(16)-C(21)  1.386(3) 
C(17)-C(18)  1.386(4) 
C(18)-C(19)  1.375(4) 





C(20)-C(21)  1.376(4) 
C(23)-C(24)  1.384(5) 
C(23)-C(28)  1.378(5) 
C(24)-C(25)  1.377(4) 
C(25)-C(26)  1.396(5) 
C(26)-C(27)  1.386(5) 
C(26)-C(29)  1.496(4) 
























































































Table S4.   Anisotropic displacement parameters  (Å2x 103) for 5a.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
S(1) 30(1)  80(1) 31(1)  -6(1) 5(1)  9(1) 
S(1B) 31(2)  45(2) 31(2)  2(1) 12(1)  1(2) 
O(1) 44(1)  30(1) 47(1)  0(1) 3(1)  -4(1) 
O(2) 39(1)  58(1) 54(1)  22(1) 10(1)  4(1) 
O(3) 26(1)  52(1) 43(1)  13(1) 1(1)  2(1) 
O(4) 33(1)  106(2) 41(2)  -9(2) 13(1)  4(1) 
O(4B) 28(5)  55(5) 41(6)  10(4) 17(4)  -10(4) 
O(5) 43(2)  77(2) 44(2)  -2(2) 0(1)  27(2) 
O(5B) 60(6)  40(5) 36(4)  0(4) 20(4)  10(4) 
N(1) 31(1)  73(2) 34(1)  -7(1) 10(1)  -4(1) 
N(1B) 35(4)  50(4) 32(3)  8(3) 10(3)  0(3) 
C(1) 28(1)  31(1) 38(1)  1(1) 4(1)  0(1) 
C(2) 28(1)  29(1) 37(1)  5(1) 1(1)  4(1) 
C(3) 24(1)  39(1) 37(1)  8(1) 1(1)  5(1) 
C(4) 32(1)  57(1) 39(1)  4(1) 1(1)  7(1) 
C(5) 36(1)  88(2) 42(1)  15(1) 10(1)  10(1) 
C(6) 34(1)  80(2) 57(2)  27(1) 10(1)  -3(1) 
C(7) 29(1)  49(1) 64(2)  21(1) 4(1)  -3(1) 
C(8) 24(1)  38(1) 47(1)  12(1) 1(1)  3(1) 
C(9) 31(1)  29(1) 49(1)  1(1) 4(1)  -1(1) 
C(10) 30(1)  36(1) 36(1)  2(1) 3(1)  -1(1) 
C(11) 27(1)  43(1) 46(1)  3(1) -5(1)  2(1) 
C(12) 30(1)  65(2) 74(2)  14(1) 6(1)  2(1) 
C(13) 46(1)  58(2) 54(2)  -8(1) -5(1)  2(1) 
C(14) 47(2)  42(1) 70(2)  -2(1) -3(1)  4(1) 
C(15) 30(1)  45(1) 37(1)  -2(1) 5(1)  1(1) 
C(16) 28(1)  41(1) 36(1)  -3(1) 5(1)  -3(1) 
C(17) 32(1)  54(1) 62(2)  14(1) -1(1)  -10(1) 
C(18) 36(1)  73(2) 63(2)  29(2) -1(1)  -6(1) 
C(19) 29(1)  77(2) 48(1)  4(1) -5(1)  -8(1) 
C(20) 34(1)  55(2) 85(2)  2(2) -6(2)  -13(1) 
C(21) 36(1)  43(1) 73(2)  8(1) -1(1)  -6(1) 
C(22) 29(1)  60(2) 38(2)  -9(2) 12(1)  -2(1) 





C(23) 43(1)  88(2) 32(1)  -7(1) 7(1)  18(1) 
C(24) 39(1)  80(2) 52(2)  -3(1) 5(1)  3(1) 
C(25) 42(1)  81(2) 42(1)  16(1) 4(1)  6(1) 
C(26) 38(1)  86(2) 41(1)  7(1) 5(1)  5(1) 
C(27) 48(2)  80(2) 59(2)  11(2) 10(2)  -1(2) 
C(28) 59(2)  88(2) 44(2)  19(2) 13(2)  21(2) 






Table S5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for 5a. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1) 8474 5144 6963 55 
H(1B) 7860 1493 7449 47 
H(4) 7088 8052 9788 52 
H(5) 6526 5602 10323 66 
H(6) 6115 2138 9900 69 
H(7) 6264 993 8958 58 
H(9A) 6534 2990 7888 45 
H(9B) 7278 2264 8234 45 
H(12A) 4966 4763 7597 86 
H(12B) 4471 6842 7370 86 
H(12C) 4993 6972 8016 86 
H(13A) 5714 7276 6480 83 
H(13B) 4933 6879 6407 83 
H(13C) 5450 4909 6681 83 
H(14A) 5487 10556 7730 84 
H(14B) 4942 10525 7096 84 
H(14C) 5716 10687 7100 84 
H(15) 7861 7175 7559 45 
H(15A) 7875 7353 7693 45 
H(17) 8333 2129 8502 62 
H(18) 9345 1744 9204 71 
H(19) 10114 4708 9367 64 
H(20) 9878 7980 8777 74 
H(21) 8868 8381 8086 63 
H(22A) 7707 2314 7464 50 
H(22B) 7236 4045 7007 50 
H(22C) 7374 5169 6805 46 
H(22D) 8167 5464 6924 46 
H(24) 7579 4965 5514 69 
H(25) 6580 5067 4787 67 
H(27) 6058 -974 5376 75 
H(28) 7042 -1021 6136 76 





H(29B) 5382 570 4464 122 
H(29C) 5725 2354 4099 122 













2. Experimental procedures 
 
2.1. General procedures for the ring-opening reactions of aryl-aziridines 4 
with β-ketoesters 1 
 
2.1.1. General procedure for the enantioselective screening and 
optimization reactions 
 
   
 
A mixture of the β-ketoester 1a (0.1 mmol, 1 equiv.), catalyst A1 (7.6 mg 0.01 mmol, 
10 mol%) and 0.2 mmol of the tested base (2 equiv.) was dissolved in 5 mL of the given 
solvent under an argon atmosphere (room temperature). Then 48 mg of  
2-phenyltosylaziridine 4a (0.2 mmol, 2 equiv.) were added in one portion. After a reaction time 
of one day the mixture was filtrated through a plug of Na2SO4 and washed with DCM. The 
crude product, obtained after evaporation of the solvent under reduced pressure, was then 
subjected to column chromatography purification (silica gel, heptanes:EtOAc = 2:1) to isolate 
product 5a as a mixture of two diastereomers (d.r. up to 8:1) in yields up to 84%. The 
diastereomers were separated using preparative HPLC (Grace Alltima Silica 10 µm 
250x10 mm, n-hexane:EtOAc = 9:1, 5 mL/min, retention times: 39.1 min major, 46.8 min 
minor). The enantiomeric excess of the minor diastereomer was determined by HPLC using 
a YMC Amylose SA column (n-hexane:i-PrOH = 3:1, 1 mL/min, 10 °C, retention times: 
21.0 and 35.5 min). The enantiomeric excess of the major diastereomer was determined by 
HPLC using a YMC Cellulose SB column (n-hexane:i-PrOH = 10:1, 1 mL/min, 10 °C, retention 




























Analytical data for compound 5a (e.r., d.r., and yield depending on 
the conditions are given in the main manuscript). 
HRMS (ESI): m/z calculated for C29H32NO5S+: 506.2001 [M+H]+; 
found:  506.1992 
Major diastereomer: 
1H-NMR (700 MHz, CDCl3, 298.0 K): δ /ppm = 7.67 (d, J = 8.2 Hz, 
2H), 7.49 (d, J = 7.7 Hz, 1H), 7.46 (t, J = 7.2 Hz, 1H), 7.32 (d, J = 7.7 Hz, 1H), 7.28 (d, 
J = 8.2 Hz, 2H), 7.21 (t, J = 7.2 Hz, 1H), 7.11-7.05 (m, 5H), 4.42-4.40 (m, 1H), 3.87 (dd, 
J1 = 9.7 Hz, J2 = 5.7 Hz, 1H), 3.69 (d, J = 17.2 Hz, 1H),  3.65-3.61 (m, 1H), 3.38-3.34 (m, 1H), 
3.22 (d, J = 17.2 Hz, 1H), 2.43 (s, 3H), 1.37 (s, 9H); 13C-NMR (176 MHz, CDCl3, 298.0 K): δ 
/ppm = 200.7, 169.0, 153.2, 143.6, 137.2, 136.2, 135.2, 135.0, 129.9, 129.6, 128.7, 127.8, 
127.6, 127.3, 126.0, 124.7, 83.1, 65.4, 48.0, 44.4, 33.3, 27.8, 21.6. 
Minor diastereomer: 
1H-NMR (700 MHz, CDCl3, 298.0 K): δ /ppm = 7.73 (d, J = 7.5 Hz, 2H), 7.56 (d, J = 8.1 Hz, 
2H), 7.56-7.54 (m, 1H), 7.37-7.34 (m, 2H), 7.22-7.18 (m, 5H), 7.11-7.08 (m, 2H), 4.20-4.18 
(m, 1H), 3.90-3.88 (m, 1H), 3.64 (d, J = 16.8 Hz, 1H),  3.40-3.36 (m, 1H), 3.33-3.29 (m, 1H), 
3.27 (d, J = 16.8 Hz, 1H), 2.40 (s, 3H), 1.20 (s, 9H); 13C-NMR (176 MHz, CDCl3, 298.0 K): δ 
/ppm = 202.1, 168.5, 153.2, 143.4, 137.9, 137.0, 135.7, 135.4, 129.8, 129.2, 128.8, 127.9, 
127.8, 127.2, 126.3, 124.7, 82.8, 65.2, 49.0, 45.5, 34.7, 27.6, 21.6. 
 




A mixture of 0.1 mmol β-ketoester 1a-h (1 equiv.), 2.2 mg TEBAC (0.01 mmol, 10 mol%) and 
0.2 mmol base (2 equiv.) was dissolved in 5 mL toluene (Ar-atmosphere). Then 0.2 mmol of 
aziridine 4a-h (2 equiv.) were added in one portion. After a reaction time of three days the 
mixture was filtrated through a plug of Na2SO4 and washed with DCM. The crude product, 
obtained after evaporation of the solvent, was subjected to column chromatography (silica 




























The diastereomers were in some cases separated using preparative HPLC (Grace Alltima 
Silica 10 µm 250x10 mm, n-hexane:EtOAc, 5 mL/min) but otherwise the mixture of 
diastereomers was analysed and in some cases the signals for the minor diastereomer were 
hardly detectable (i.e. in the 13C NMR) and mainly assigned with HSQC and HMBC methods. 
 
Compound 5b was prepared according to the general procedure 
described in 2.1.2 using Cs2CO3 as base and was obtained as a 
white residue in a yield of 4%. Only one diastereomer was 
detected. 
HRMS (ESI): m/z calculated for C23H31N2O5S+: 447.1954 
[M+NH4]+; found: 447.1946 
1H-NMR (700 MHz, CDCl3, 298.0 K): δ /ppm = 7.72 (d, J = 7.6 Hz, 
1H), 7.63 (t, J = 7.8 Hz, 1H), 7.52 (d, J = 7.8 Hz, 1H), 7.41-7.29 (m, 10H), 5.70 (d, J = 7.6 Hz, 
1H), 4.70-4.67 (m, 1H), 3.77 (d, J = 7.5 Hz, 1H), 3.27 (d, J = 17.2 Hz, 1H), 2.94 (dd, 




Compound 6 was prepared by the general procedure described 
in 2.1.2 starting from 1c or 1d using Cs2CO3 or K3PO4 (54% yield 
from 1d and 17% from 1c). Only one diastereomer was formed. 
HRMS (ESI): m/z calculated for C25H25N2O4S+: 449.1535 
[M+NH4]+; found: 449.1528 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 8.02 (d, 
J = 8.3 Hz, 1H), 7.47-7.42 (m, 1H), 7.36 (d, J = 4.1 Hz, 2H), 7.37-7.32 (m, 2H), 7.20-7.13 (m, 
6H), 4.68 (dd, J1 = 11.4 Hz, J2 = 9.4 Hz, 1H), 4.33 (dd, J1 = 9.4 Hz, J2 = 7.8 Hz, 1H), 3.80-
3.73 (m, 1H), 3.73 (d, J = 17.5 Hz, 1H), 3.12 (d, J = 17.5 Hz, 1H), 2.45 (s, 3H); 13C-NMR 
(176 MHz, CDCl3, 298.0 K): δ /ppm = 201.1, 171.0, 153.0, 145.5, 135.7, 135.0, 134.9, 133.5, 
















Compound 5e was prepared by the general procedure described 
in 2.1.2 using K3PO4 as base and was obtained as a colourless 
residue in a yield of 63% and with a d.r. of 1:4. 
HRMS (ESI): m/z calculated for C29H34ClN2O5S+: 557.1877 
[M+NH4]+; found: 557.1870 
 
Major diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.67 (d, J = 8.3 Hz, 2H), 7.41 (d, J = 8.2 Hz, 
1H), 7.32-7.27 (m, 3H), 7.20-7.17 (m, 1H), 7.12-7.09 (m, 3H), 7.04-7.01 (m, 2H), 4.39-4.37 
(m, 1H), 3.93-3.89 (m, 1H), 3.68 (d, J = 17.3 Hz, 1H), 3.64-3.55 (m, 1H), 3.36-3.28 (m, 1H), 
3.20 (d, J = 17.3 Hz, 1H), 2.43 (s, 3H), 1.38 (s, 9H); 13C-NMR (176 MHz, CDCl3, 298.0 K): δ 
/ppm = 199.4, 168.9, 154.7, 144.1, 143.7, 135.7, 133.4, 129.9, 129.5, 128.8, 128.5, 128.0, 
127.3, 126.3, 125.7, 109.4, 83.5, 65.5, 47.8, 44.1, 32.7, 27.8, 21.7. 
Minor diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.67 (d, J = 8.3 Hz, 1H), 7.54 (d, J = 8.2 Hz, 
2H), 7.36-7.20 (m, 8H), 7.10-7.07 (m, 1H),  4.15-4.12 (m, 1H), 3.94-3.88 (m, 1H), 3.64 (d, 
J = 17.1 Hz, 1H), 3.36-3.26 (m, 1H), 3.27 (d, J = 22.2 Hz, 1H), 2.41 (s, 3H), 1.38 (s, 9H). 
 
Compound 5f was prepared by the general procedure described 
in 2.1.2 using K3PO4 as base and was obtained as a white residue 
in a yield of 79% and with a d.r. of 1:6. 
HRMS (ESI): m/z calculated for C29H34BrN2O5S+: 601.1372 
[M+NH4]+; found: 601.1363 
 
Major diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.66 (d, J = 4.2 Hz, 2H), 7.51 (s, 1H), 7.34-
7.27 (m, 4H), 7.11-7.08 (m, 3H), 7.03-7.00 (m, 2H), 4.37 (dd, J1 = 8.5 Hz, J2 = 3.7 Hz, 1H), 
3.90 (dd, J1 = 9.8 Hz, J2 = 5.7 Hz, 1H), 3.68 (d, J = 17.5 Hz, 1H), 3.64-3.54 (m, 1H), 3.36-3.28 
(m, 1H), 3.20 (d, J = 17.5 Hz, 1H), 2.43 (s, 3H), 1.38 (s, 9H); 13C-NMR (176 MHz, CDCl3, 
298.0 K): δ /ppm = 200.5, 168.5, 154.8, 143.8, 143.7,  136.9, 135.7, 133.7, 131.3, 130.8, 



















1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.59 (d, J = 8.2 Hz, 1H), 7.55-7.49 (m, 4H), 
7.23-7.20 (m, 5H), 7.10-7.07 (m, 2H), 4.15-4.12 (m, 1H), 3.91 (t, J = 8.1 Hz, 1H), 3.64 (d, 
J = 17.0 Hz, 1H), 3.37-3.32 (m, 1H), 3.29-3.24 (m, 1H), 3.26 (d, J = 17.0 Hz, 1H), 2.41 (s, 
3H), 1.18 (s, 9H); 13C-NMR (176 MHz, CDCl3, 298.0 K): δ /ppm = 200.9, 168.0, 154.8, 143.6, 
137.8, 136.7, 134.2, 131.5, 131.0, 129.8, 129.6, 129.1, 128.9, 128.0, 127.1, 125.8, 83.1, 65.4, 
48.7, 45.7, 29.8, 27.5, 21.7. 
 
Compound 5g was prepared by the general procedure described 
in 2.1.2 using Cs2CO3 as base and was obtained as a white solid 
in a yield of 50% and with a d.r. of 1:3.5. 
HRMS (ESI): m/z calculated for C29H34BrN2O5S+: 601.1372 
[M+NH4]+; found: 601.1368 
Major diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.67 (d, J = 8.3 Hz, 2H), 7.60-7.55 (m, 2H), 
7.30-7.21 (m, 3H), 7.12-7.09 (m, 3H), 7.04-7.01 (m, 2H), 4.40-4.36 (m, 1H), 3.94-3.88 (m, 
1H), 3.65-3.54 (m, 1H), 3.60 (d, J = 17.2 Hz, 1H), 3.36-3.28 (m, 1H), 3.15 (d, J = 17.2 Hz, 
1H), 2.43 (s, 3H), 1.37 (s, 9H); 13C-NMR (176 MHz, CDCl3, 298.0 K): δ /ppm = 199.3, 168.5, 
151.8, 143.7, 138.0, 136.9, 136.7, 135.7, 129.9, 129.5, 128.8, 128.0, 127.5, 127.4, 127.2, 
121.7, 83.5, 65.8, 47.7, 44.2, 32.7, 27.8, 21.7. 
Minor diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.85-7.53 (m, 3H), 7.28-7.20 (m, 8H), 7.10-
7.07 (m, 1H), 4.17-4.11 (m, 1H), 3.93-3.82 (m, 1H), 3.61 (d, J = 17.0 Hz, 1H), 3.39-3.23 (m, 
1H), 3.25 (d, J = 17.0 Hz, 1H), 2.41 (s, 3H), 1.18 (s, 9H); 13C-NMR (176 MHz, CDCl3, 
298.0 K): δ /ppm = 200.8, 168.0, 151.8, 144.1, 143.6, 138.2, 137.2, 136.7, 129.8, 129.1, 
128.9, 128.0, 127.8, 127.5, 127.2, 121.9, 83.1, 65.7, 48.9, 31.7, 27.6, 22.8, 14.3. 
 
Compound 5h was prepared by the general procedure 
described in 2.1.2 using Cs2CO3 as base and was obtained as a 
white solid in a yield of 74% and with a d.r. of 1:4.5. 
HRMS (ESI): m/z calculated for C30H37N2O6S+: 553.2372 


















1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.67 (d, J = 8.3 Hz, 2H), 7.30-7.20 (m, 3H), 
7.11-7.04 (m, 6H), 6.92-6.91 (m, 1H), 4.42-4.38 (m, 1H), 3.92-3.87 (m, 1H), 3.73 (s, 3H), 3.65-
3.56 (m, 1H), 3.60 (d, J = 17.1 Hz, 1H), 3.37-3.28 (m, 1H), 3.15 (d, J = 17.1 Hz, 1H), 2.43 (s, 
3H), 1.37 (s, 9H); 13C-NMR (176 MHz, CDCl3, 298.0 K): δ /ppm = 200.6, 169.0, 159.5, 146.1, 
143.5, 137.1, 136.2, 136.1, 129.8, 129.6, 128.7, 127.8, 127.3, 126.7, 124.7, 105.7, 83.1, 66.1, 
55.6, 48.0, 44.4, 32.7, 27.8, 21.6. 
Minor diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.60-7.55 (m, 3H), 7.24-7.14 (m, 9H), 4.22-
4.17 (m, 1H), 3.92-3.84 (m, 1H), 3.83 (s, 3H), 3.74 (d, J = 17.7 Hz, 1H), 3.55 (d, J = 16.9 Hz, 
1H), 3.38-3.30 (m, 1H), 3.17 (d, J = 16.9 Hz, 1H), 2.41 (s, 3H), 1.21 (s, 9H); 13C-NMR 
(176 MHz, CDCl3, 298.0 K): δ /ppm = 201.9, 168.5, 159.7, 146.1, 143.3, 137.8, 137.0, 136.8, 




Compound 5i was prepared by the general procedure described 
in 2.1.2 using K3PO4 as base and was obtained as a colourless 
residue in a yield of 39% and with a d.r. of 1:5. 
HRMS (ESI): m/z calculated for C30H37N2O5S+: 537.2423 
[M+NH4]+; found: 537.2415 
 
Major diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.68 (d, J = 8.3 Hz, 2H), 7.34-7.30 (m, 4H), 
7.13 (d, J = 7.5 Hz, 1H), 7.09-7.04 (m, 5H), 4.42-4.38 (m, 1H), 3.92-3.87 (m, 1H), 3.66-3.57 
(m, 1H), 3.56 (d, J = 17.4 Hz, 1H), 3.43-3.34 (m, 1H), 3.04 (d, J = 17.4 Hz, 1H), 2.43 (s, 3H), 
2.28 (s, 3H), 1.37 (s, 9H); 13C-NMR (176 MHz, CDCl3, 298.0 K): δ /ppm = 200.8, 168.9, 152.0, 
143.5, 137.2, 136.1, 135.6, 135.1, 134.7, 129.8, 129.5, 128.6, 127.8, 127.7, 127.3, 122.0, 
83.1, 65.4, 48.1, 44.2, 32.1, 27.8, 21.6, 17.8 
Minor diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.61-7.53 (m, 3H), 7.39-7.30 (m, 2H), 7.22-
7.20 (m, 5H), 7.13-7.10 (m, 2H), 4.20-4.14 (m, 1H), 3.93 (t, J = 8.3 Hz, 1H), 3.59 (d, 
J = 17.1 Hz, 1H), 3.34-3.27 (m, 1H), 3.11 (d, J = 17.1 Hz, 1H), 2.41 (s, 3H), 2.30 (s, 3H), 1.19 










137.0, 135.9, 135.5, 135.3, 129.7, 129.1, 128.7, 127.9, 127.8, 127.2, 122.0, 82.7, 65.3, 48.9, 
45.6, 33.2, 27.6, 21.6, 17.8 
 
Compound 5j was prepared by the general procedure described in 
2.3.2 using Cs2CO3 as base and was obtained as a white residue 
in a yield of 80% and with a d.r. of 1:4. 
HRMS (ESI): m/z calculated for C29H34ClN2O5S+: 557.1877 
[M+NH4]+; found: 557.1883 
Major diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.65 (d, J = 8.3 Hz, 2H), 7.52-7.48 (m, 2H), 
7.36-7.22 (m, 4H), 7.07-6.98 (m, 4H), 4.41-4.37 (m, 1H), 3.90-3.85 (m, 1H), 3.69 (d, 
J = 17.2 Hz, 1H), 3.62-3.53 (m, 1H), 3.35-3.26 (m, 1H), 3.18 (d, J = 17.2 Hz, 1H), 2.43 (s, 
3H), 1.35 (s, 9H); 13C-NMR (176 MHz, CDCl3, 298.0 K): δ /ppm = 200.6, 168.8, 153.0, 143.7, 
136.9, 135.5, 134.8, 133.8, 130.9, 129.9, 128.8, 127.8, 127.2, 126.0, 125.0, 124.8, 83.3, 65.1, 
47.3, 44.4, 33.2, 27.8, 21.7 
Minor diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.73 (d, J = 7.3 Hz, 1H), 7.58 (d, J = 9.2 Hz, 
1H), 7.53 (d, J = 8.3 Hz, 2H), 7.37 (d, J = 7.1 Hz, 2H), 7.20 (d, J = 8.1 Hz, 2H), 7.14 (d, 
J = 8.5 Hz, 2H), 7.00 (d, J = 8.5 Hz, 2H), 4.23-4.19 (m, 1H), 3.88-3.83 (m, 1H), 3.60 (d, 
J = 16.7 Hz, 1H), 3.35-3.27 (m, 2H), 3.20 (d, J = 16.7 Hz, 1H), 2.40 (s, 3H), 1.21 (s, 9H); 13C-
NMR (176 MHz, CDCl3, 298.0 K): δ /ppm = 201.8, 168.4, 153.0, 143.5, 136.7, 136.4, 135.6, 
133.7, 130.5, 129.8, 129.8, 128.9, 127.9, 127.3, 127.1, 126.3, 124.7, 83.0, 64.9, 48.5, 45.4, 
34.6, 27.5, 21.7 
 
Compound 5k was prepared by the general procedure described in 
2.1.2 using Cs2CO3 as the base and was obtained as a white 
residue in a yield of 37% and with a d.r. of 2:1. 
HRMS (ESI): m/z calculated for C29H34ClN2O5S+: 557.1877 
[M+NH4]+; found: 557.1869 
Major diastereomer: 
1H-NMR (700 MHz, CDCl3, 298.0 K): δ /ppm = 7.66 (d, J = 8.2 Hz, 2H), 7.53-7.49 (m, 2H), 
7.36 (d, J = 7.6 Hz, 1H), 7.28-7.23 (m, 3H), 7.07-7.03 (m, 2H), 6.99-6.97 (m, 2H), 4.45-4.43 
(m, 1H), 3.81 (dd, J1 = 9.5 Hz, J2 = 5.7 Hz, 1H), 3.69 (d, J = 17.2 Hz, 1H), 3.65-3.62 (m, 1H), 

















CDCl3, 298.0 K): δ /ppm = 200.4, 168.8, 152.9, 143.7, 138.6, 137.1, 135.4, 134.9, 134.5, 
129.9, 129.5, 128.0, 127.9, 127.2, 126.0, 124.7, 83.3, 65.0, 47.9, 44.4, 33.7, 27.8, 21.6. 
Minor diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.75 (d, J = 8.0 Hz, 1H), 7.61-7.54 (m, 3H), 
7.41-7.37 (m, 2H), 7.22-7.14 (m, 5H), 7.02-7.00 (m, 2H), 4.23-4.19 (m, 1H), 3.89-3.84 (m, 
1H), 3.66 (d, J = 16.8 Hz, 1H), 3.37-3.26 (m, 2H), 3.23 (d, J = 16.8 Hz, 1H), 2.41 (s, 3H), 1.21 
(s, 9H); 13C-NMR (176 MHz, CDCl3, 298.0 K): δ /ppm = 201.2, 168.0, 143.5, 140.1, 135.6, 
135.4, 130.0, 129.8, 129.8, 129.7, 128.0, 127.9, 127.3, 127.2, 127.1, 127.0, 126.3, 124.7, 
83.0, 65.1, 48.6, 45.3, 34.3, 27.5, 21.6. 
 
 
Compound 5l was prepared by the general procedure described in 
2.1.2 using Cs2CO3 as base and was obtained as a white residue 
in a yield of 96% and with a d.r. of 1:3. 
HRMS (ESI): m/z calculated for C29H34BrN2O5S+: 601.1372 
[M+NH4]+; found: 601.1360 
 
Major diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.64 (d, J = 8.2 Hz, 2H), 7.53-7.48 (m, 2H), 
7.40-7.28 (m, 4H), 7.21 (d, J = 8.5 Hz, 2H), 6.94 (d, J = 8.5 Hz, 2H), 4.41-4.37 (m, 1H), 3.89-
3.84 (m, 1H), 3.69 (d, J = 17.3 Hz, 1H), 3.57-3.52 (m, 1H), 3.34-3.29 (m, 1H), 3.17 (d, J = 17.3 
Hz, 1H), 2.43 (s, 3H), 1.35 (s, 9H); 13C-NMR (176 MHz, CDCl3, 298.0 K): δ /ppm = 200.7, 
168.8, 143.7, 136.9, 135.3, 134.8, 131.8, 131.2, 129.9, 127.8, 127.2, 126.4, 126.0, 124.8, 
121.9, 83.3, 65.1, 47.4, 44.4, 33.3, 27.8, 21.7. 
 
 
Compound 5m was prepared by the general procedure described 
in 2.1.2 using K3PO4 as base and was obtained as a white residue 
in a yield of 75% and with a d.r. of 1:2.5. 
HRMS (ESI): m/z calculated for C29H34FN2O5S+: 541.2172 



















1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.67 (d, J = 8.3 Hz, 2H), 7.52-7.47 (m, 2H), 
7.36-7.21 (m, 4H), 7.06-7.01 (m, 2H), 6.83-6.75 (m, 2H), 4.41-4.37 (m, 1H), 3.93-3.88 (m, 
1H), 3.70 (d, J = 17.3 Hz, 1H), 3.62-3.51 (m, 1H), 3.35-3.26 (m, 1H), 3.19 (d, J = 17.3 Hz, 
1H), 2.43 (s, 3H), 1.36 (s, 9H); 13C-NMR (176 MHz, CDCl3, 298.0 K): δ /ppm = 201.2, 168.9, 
144.0, 143.6, 137.1, 135.3, 132.0, 131.2, 131.1, 129.8, 129.5, 127.7, 127.2, 126.7, 126.0, 
124.7, 115.6, 83.2, 65.2, 47.3, 44.5, 33.3, 28.0, 21.6. 
 
 
Compound 5n was prepared by the general procedure described 
in 2.1.2 using Cs2CO3 as base and was obtained as a colourless 
residue in a yield of 89% and with a d.r. of 1:3. 
HRMS (ESI): m/z calculated for C30H37N2O5S+: 537.2423 
[M+NH4]+; found: 537.2419 
 
Major diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.67 (d, J = 8.3 Hz, 2H), 7.52-7.45 (m, 2H), 
7.35-7.19 (m, 4H), 6.95-6.88 (m, 4H), 4.39-4.36 (m, 1H), 3.89-3.84 (m, 1H), 3.68 (d, 
J = 17.3 Hz, 1H), 3.64-3.54 (m, 1H), 3.35-3.26 (m, 1H), 3.21 (d, J = 17.3 Hz, 1H), 2.43 (s, 
3H), 2.18 (s, 3H), 1.37 (s, 9H); 13C-NMR (176 MHz, CDCl3, 298.0 K): δ /ppm = 200.6, 168.9, 
153.2, 143.5, 137.5, 137.2, 135.1, 135.0, 132.9, 129.8, 129.4, 129.4, 127.5, 127.3, 126.0, 
124.6, 83.0, 65.5, 47.5, 44.3, 33.2, 27.8, 21.0, 14.2. 
Minor diastereomer: 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.74-7.65 (m, 2H), 7.59-7.45 (m, 3H), 7.36 (d, 
J = 8.0 Hz, 1H), 7.22 (d, J = 7.9 Hz, 2H), 6.97 (d, J = 4.1 Hz, 2H), 6.91 (d, J = 3.8 Hz, 2H), 
4.39-4.35 (m, 1H), 3.88-3.80 (m, 1H), 3.64 (t, J = 17.8 Hz, 1H), 3.36-3.18 (m, 3H), 2.41 (d, 












Compound 5o was prepared by the general procedure described in 
2.3.2 using K3PO4 as base and was obtained as a white residue in 
a yield of 90%. Only one diastereomer was formed. 
HRMS (ESI): m/z calculated for C33H43N2O5S+: 579.2893 [M+NH4]+; 
found: 579.2887 
1H-NMR (300 MHz, CDCl3, 298.0 K): δ /ppm = 7.67 (d, J = 8.2 Hz, 
2H), 7.49-7.43 (m, 2H), 7.33-7.16 (m, 4H), 7.08 (d, J = 8.4 Hz, 2H), 6.95 (d, J = 8.4 Hz, 2H), 
4.41-4.37 (m, 1H), 3.85-3.80 (m, 1H), 3.67 (d, J = 17.5 Hz, 1H), 3.62-3.55 (m, 1H), 3.37-3.28 
(m, 1H), 3.20 (d, J = 17.5 Hz, 1H), 2.42 (s, 3H), 1.36 (s, 9H), 1.17 (s, 9H); 13C-NMR (176 MHz, 
CDCl3, 298.0 K): δ /ppm = 200.7, 169.0, 153.2, 150.7, 143.5, 137.2, 135.0, 132.8, 129.8, 












3. Illustrative NMR Spectra of New Compounds 
NOTE: Diastereomers had to be separated by semiprep. HPLC and the minor 
diastereomers could only be obtained in rather small and diluted amounts (if possible at 
































             






























































































































































































      
 























































































    
 











































































































4. HPLC Traces 
 
Determination of the diastereomeric ratio of racemic 5a by HPLC (YMC-SA) 
 
21.04 min: minor diastereomer, first enantiomer  
26.61 min: major diastereomer, both enantiomers 








Product 5a major diastereomer (racemic mixture) 
 
Product 5a major diastereomer (enantiomer-enriched mixture) 
 
 
 
 
